Jeffrey M. Johnston
Keine laufenden Positionen mehr
Karriereverlauf von Jeffrey M. Johnston
Ehemalige bekannte Positionen von Jeffrey M. Johnston
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2005 | 01.01.2016 |
| RA PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2016 | - |
| GSK PLC | Corporate Officer/Principal | - | - |
Triangle Pharmaceuticals, Inc.
 Triangle Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Triangle Pharmaceuticals Inc. provided antiviral drug candidates for the human immunodeficiency virus. The company was founded in 1995 and was located in Durham, NC. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
| Critical Therapeutics, Inc. | Technik-/Wissenschafts-/F&E-Leiter | 20.06.2011 | - |
| Corporate Officer/Principal | - | 20.06.2011 |
Ausbildung von Jeffrey M. Johnston
| Davidson College | Undergraduate Degree |
| Duke University School of Medicine | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
| Vereinigtes Königreich | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 4 |
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
| GSK PLC | Health Technology |
| Private Unternehmen | 3 |
|---|---|
| Critical Therapeutics, Inc. | Health Technology |
Triangle Pharmaceuticals, Inc.
Triangle Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Triangle Pharmaceuticals Inc. provided antiviral drug candidates for the human immunodeficiency virus. The company was founded in 1995 and was located in Durham, NC. | Commercial Services |
Ra Pharmaceuticals, Inc.
 Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides. The company was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- Jeffrey M. Johnston
- Erfahrung